Bio-Lab, Inc. v. United States

435 F. Supp. 3d 1361, 2020 CIT 45
CourtUnited States Court of International Trade
DecidedApril 7, 2020
Docket18-00155
StatusPublished
Cited by2 cases

This text of 435 F. Supp. 3d 1361 (Bio-Lab, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bio-Lab, Inc. v. United States, 435 F. Supp. 3d 1361, 2020 CIT 45 (cit 2020).

Opinion

Slip Op. 20–

UNITED STATES COURT OF INTERNATIONAL TRADE __________________________________________ : BIO-LAB, INC., CLEARON CORP. and : OCCIDENTAL CHEMICAL CORP., : : Plaintiffs, : : Before: Richard K. Eaton, Judge v. : : Court No. 18-00155 UNITED STATES, : : Defendant, : : and : : JUANCHENG KANGTAI CHEMICAL CO., LTD. : and HEZE HUAYI CHEMICAL CO., LTD., : : Defendant-Intervenors. : __________________________________________:

OPINION

[United States Department of Commerce’s Final Results are sustained.]

Dated$SULO

James R. Cannon, Jr., Cassidy Levy Kent (USA) LLP, of Washington, DC, argued for Plaintiffs. With him on the brief was Ulrika K. Swanson.

Sonia M. Orfield, Trial Attorney, Commercial Litigation Branch, Civil Division, U.S. Department of Justice, of Washington, DC, argued for Defendant. With her on the brief were Joseph H. Hunt, Acting Assistant Attorney General, Jeanne E. Davidson, Director, and Patricia M. McCarthy, Assistant Director. Of counsel on the brief was Catherine Miller, Attorney, Office of the Chief Counsel for Import Administration, U.S. Department of Commerce, of Washington, DC.

Gregory S. Menegaz, deKieffer & Horgan, PLLC, of Washington, DC, argued for Defendant-Intervenors. With him on the brief were J. Kevin Horgan and Alexandra H. Salzman. Court No. 18-00155 Page 2

Eaton, Judge: Bio-Lab, Inc., Clearon Corp., and Occidental Chemical Corp. (“Plaintiffs”)

are U.S. domestic producers of chlorinated isocyanurates1 and the petitioners in this proceeding.

They challenge the United States Department of Commerce’s (“Commerce” or the “Department”)

final results published in Chlorinated Isocyanurates From the People’s Republic of China, 83 Fed.

Reg. 26,954 (Dep’t Commerce June 11, 2018) (“Final Results”), and the accompanying Issues and

Decision Mem. (June 5, 2018), P.R. 72 (“Final IDM”).

In the Final Results, Commerce determined that Defendant-Intervenors and mandatory

respondents Juancheng Kangtai Chemical Co., Ltd. (“Kangtai”) and Heze Huayi Chemical Co.,

Ltd. (“Heze”), Chinese producers and exporters of the chemicals, received countervailable

subsidies during the period of review, including through a loan program called the Export Buyer’s

Credit Program.2 See Final IDM at 1. It made this determination on the basis of adverse inferences,

having found that the use of adverse facts available (“AFA”)3 was warranted because the

1 Chlorinated isocyanurates, the subject chemicals, are “derivatives of cyanuric acid, described as chlorinated s-triazine triones” that are used for, among other things, water treatment. See Final IDM at 2; Chlorinated Isocyanurates from the People’s Rep. of China, 79 Fed. Reg. 67,424 (Dep’t Commerce Nov. 13, 2014) (countervailing duty order). 2 The Export Buyer’s Credit Program provides credit at preferential rates to foreign purchasers of goods exported by Chinese companies in order to promote exports. See Clearon Corp. v. United States, 43 CIT __, 359 F. Supp. 3d 1344, 1347 (2019). The program has been the subject of much litigation before this Court. See, e.g., Yama Ribbons & Bows Co. v. United States, No. 18-00054, 2019 WL 7373856, at *7 n.7 (CIT Dec. 30, 2019) (collecting cases). 3 Before Commerce may use AFA, it must make two separate findings. First, Commerce shall use facts available “[i]f . . . necessary information is not available on the record, or . . . an interested party or any other person . . . fails to provide . . . information [that has been requested by Commerce] . . . in the form and manner requested,” or “significantly impedes” a proceeding. 19 U.S.C. § 1677e(a)(1)-(2)(B), (C). Second, if Commerce determines that the use of facts available is warranted, it must make the requisite additional finding that “an interested party has failed to cooperate by not acting to the best of its ability to comply with a request for information” before it may use an adverse inference “in selecting from among the facts otherwise available.” Id. § 1677e(b)(1). Court No. 18-00155 Page 3

Government of China (1) failed to provide necessary information about the operation of the Export

Buyer’s Credit Program, and (2) failed to act to the best of its ability to cooperate with Commerce’s

requests for information about the program.4 See 19 U.S.C. § 1677e(a), (b); Final IDM at 5-6. To

determine an AFA rate for the Export Buyer’s Credit Program, Commerce used a hierarchy it

developed for administrative reviews. See 19 U.S.C. § 1677e(d).5 Applying step two of the

hierarchy, the Department selected the rate of 0.87 percent ad valorem as a component of the final

subsidy rate calculated for Kangtai and Heze. See Final IDM at 12. This rate had previously been

determined in an earlier segment of the same proceeding for a Chinese government loan program

called the Export Seller’s Credit Program. Commerce found the Export Seller’s Credit Program to

be “similar” to the Export Buyer’s Credit Program because each conferred a similar benefit: access

to government-subsidized loans. See Final IDM at 12; 19 U.S.C. § 1677e(d)(1)(A)(i) (emphasis

added) (permitting Commerce to “use a countervailable subsidy rate applied for the same or

similar program in a countervailing duty proceeding involving the same country”).

Quite naturally, Plaintiffs do not question Commerce’s finding that the use of AFA was

warranted. Nor do Plaintiffs dispute the lawfulness of the hierarchy that Commerce used to select

an AFA rate for the Export Buyer’s Credit Program. Rather, they argue that the hierarchy, as

4 It is worth noting that, while the Department found that the respondents benefitted from the Export Buyer’s Credit Program, based on AFA, the only evidence on the record regarding use is that the respondents’ U.S. customers did not use the program. See Kangtai’s Sec. III Quest. Resp. (Apr. 12, 2017), Ex. 15, C.R. 15; Heze’s Sec. III Quest. Resp. (Apr. 12, 2017), Ex. 12, C.R. 7. 5 In pertinent part, this subsection provides that if Commerce “uses an inference that is adverse to the interests of a party under [19 U.S.C. § 1677e(b)(1)(A)] in selecting among the facts otherwise available,” Commerce “may . . . in the case of a countervailing duty proceeding . . . (i) use a countervailable subsidy rate applied for the same or similar program in a countervailing duty proceeding involving the same country; or (ii) if there is no same or similar program, use a countervailable subsidy rate for a subsidy program from a proceeding that [Commerce] considers reasonable to use.” 19 U.S.C. § 1677e(d)(1). Court No. 18-00155 Page 4

applied here, resulted in a rate for the program that is “simply too low to induce” the Government

of China to cooperate with Commerce’s requests for information in the future. See Pls.’ Reply Br.

Supp. Mot. J. Admin. R., ECF No. 37, 6; Pls.’ Mem. Supp. Mot. J. Admin. R., ECF No. 26-1

(“Pls.’ Br.”) 3. Thus, for Plaintiffs, the rate fails to satisfy the purpose of the AFA statute and,

therefore, is contrary to law. See Pls.’ Br. 3; 19 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bio-Lab, Inc. v. United States
487 F. Supp. 3d 1291 (Court of International Trade, 2020)
Clearon Corp. v. United States
474 F. Supp. 3d 1339 (Court of International Trade, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
435 F. Supp. 3d 1361, 2020 CIT 45, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bio-lab-inc-v-united-states-cit-2020.